Earnings Preview: Viking Therapeutics
Portfolio Pulse from Benzinga Insights
Viking Therapeutics (NASDAQ:VKTX) is set to release its quarterly earnings report on July 26, 2023. Analysts estimate an EPS of $-0.19. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $14.51, up 360.06% over the last 52-week period.
July 25, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Viking Therapeutics is expected to report an EPS of $-0.19 in its upcoming earnings. The stock has seen significant growth over the past year, which may influence investor sentiment.
The upcoming earnings report is a significant event for Viking Therapeutics. While the estimated EPS is negative, the stock has performed well over the past year, which may influence investor sentiment. However, the impact on the stock price will depend on the actual earnings reported and any guidance provided by the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100